2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee
Abstract

Research Snapshot Theater: Shock/Pharmacology, Adult

Sunday, March 22, 2026
2:30 PM - 3:30 PM Central Time
Location: Connections Central - RST 16

    RST Moderator(s)

  • AB

    Albert Bui, MD, PharmD

    Critical Care Fellow
    Cleveland Clinic Foundation

    Disclosure information not submitted.

  • AM

    Alyssa Meester, PharmD, BCCCP

    Specialty Practice Pharmacist - Critical Care
    Ohio State University Wexner Medical Center

    Disclosure information not submitted.

Presentations:

  • 2:30 PM - 3:30 PM Central Time
    Use of Methylene Blue in Refractory Shock and Its Impact on Vasopressor Requirements

    Sarah P. Kelly, PharmD (she/her/hers) – Advocate Christ Medical Center

    George Gavrilos, PharmD, MA, BCCCP – Advocate Christ Medical Center

    Tahar Baziz, PharmD, BCPS – Advocate Christ Medical Center

    Emily Ball, PharmD, BCCCP – Advocate Christ Medical Center

  • 2:30 PM - 3:30 PM Central Time
    Bedside Angiotensin II Admixture Improves Time to Administration and Cost in Critically Ill Adults

    Alyssia Calhoun, PharmD (she/her/hers) – University of Chicago Medicine

    Paige Fields, PharmD

    Patrick Costello, PharmD, BCCCP – University of Chicago Medical Center

  • 2:30 PM - 3:30 PM Central Time
    Correlation of Random Cortisol Levels, Corticosteroid Initiation, and Vasopressor Use

    Petra Erhardt, PharmD (she/her/hers) – CommonSpirit St Anthony Hospital

    Eric Brown, PharmD, BCCCP – UCHealth Memorial Hospital

  • 2:30 PM - 3:30 PM Central Time
    Midodrine Utilization After Medical Intensive Care Unit Initiation

    Larissa L. Hipps, PharmD (she/her/hers)

    Taylor Hodle, PharmD, BCCCP – Baystate Medical Center

    Joshua Allgaier, DO – Baystate Medical Center

  • 2:30 PM - 3:30 PM Central Time
    Evaluating Dosing of Midodrine for Acceleration of Weaning Norepinephrine in the Intensive Care Unit

    Jacob Karr, Pharm.D. – Geisinger Medical Center

    Temeka Lewis-Wolfson, PharmD, BCPS, BCCCP – Winchester Medical Center at Valley Health Systems

    Marcia Brackbill, Pharm.D., BCPS – Shenandoah University Bernard J. Dunn School of Pharmacy

  • 2:30 PM - 3:30 PM Central Time
    Droxidopa Administration via Enteral Tube for Vasopressor Weaning in a Medical Intensive Care Unit

    Caroline Popielaski, PharmD

    Keith Falsetta, PharmD, BCCCP – Long Island Jewish Medical Center

    Krislyn Schweiger, PharmD, BCPS, BCCCP – Long Island Jewish Medical Center

    Zubair Hasan, MD, FCCP – Long Island Jewish Medical Center

    Kelvin Wong, MD – Long Island Jewish Medical Center

    Daniel Ying, DO – Mount Sinai Hospital System

    Parth Pancholi, MD

    Xueqi Huang, MS – Northwell Health

  • 2:30 PM - 3:30 PM Central Time
    Hemodynamic Response to Low vs High Dose Angiotensin II in Patients With Septic Shock

    Paige Fields, PharmD

    Catherine Donaldson, PharmD, BCCCP – Ochsner Medical Center

    Patrick Costello, PharmD, BCCCP – University of Chicago Medical Center

  • 2:30 PM - 3:30 PM Central Time
    A Unique Case of Profound Linezolid-Induced Lactic Acidosis in the Setting of Septic Shock

    Roarke Swank, M.D. (he/him/his)

    Zyad Smiley, D.O. – University of Louisville

    Rea Pavate, M.D. – University of Louisville

    Patrisha Shelley, D.O. – University of Louisville